ERANOV PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ERANOV PHARMA
Largest movements
- Receivables within one year +€42,755
up €42,755 (+136%), from €31,360 to €74,115
of which Trade receivables: +€27,541
- Tangible fixed assets -€1,873
down €1,873 (-16.8%), from €11,175 to €9,302
of which Plant, machinery and equipment: -€1,122
- Tax, wage and social debts +€10,990
up €10,990 (+170%), from €6,450 to €17,440
of which Taxes: +€10,990
- Profit (loss) carried forward +€10,757
up €10,757 (+14.2%), from €75,996 to €86,753
- Trade debts +€9,189
up €9,189 (+35.1%), from €26,158 to €35,347
- Other debts +€6,137
up €6,137 (+450%), from €1,363 to €7,500
- Short-term financial debts +€4,053
new in 2025: €4,053
- Gross operating margin +€30,855
up €30,855 (+1,046%), from €2,949 to €33,805
- Taxes +€4,471
up €4,471 (+661%), from €677 to €5,148
- Financial charges -€2,331
down €2,331 (-26.0%), from €8,960 to €6,629
- Financial income -€2,218
down €2,218 (-32.4%), from €6,848 to €4,629
- Other operating charges +€1,761
up €1,761 (+212%), from €829 to €2,590
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €111,967 | €153,094 | +€41,127 | +36.7% |
| Fixed assets | 21/28 | €11,175 | €9,302 | -€1,873 | -16.8% |
| Tangible fixed assets | 22/27 | €11,175 | €9,302 | -€1,873 | -16.8% |
| Plant, machinery and equipment | 23 | €9,861 | €8,739 | -€1,122 | -11.4% |
| Furniture and vehicles | 24 | €1,313 | €563 | -€751 | -57.2% |
| Current assets | 29/58 | €100,793 | €143,792 | +€42,999 | +42.7% |
| Amounts receivable after more than one year | 29 | €69,285 | €69,285 | = | 0.0% |
| Other amounts receivable | 291 | €69,285 | €69,285 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €31,360 | €74,115 | +€42,755 | +136% |
| Trade receivables | 40 | €30,388 | €57,929 | +€27,541 | +90.6% |
| Other amounts receivable | 41 | €972 | €16,186 | +€15,215 | +1,566% |
| Cash at bank and in hand | 54/58 | €148 | €111 | -€37 | -25.0% |
| Deferred charges and accrued income | 490/1 | €0 | €281 | +€281 | |
| Total equity and liabilities | 10/49 | €111,967 | €153,094 | +€41,127 | +36.7% |
| Equity | 10/15 | €77,996 | €88,753 | +€10,757 | +13.8% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €75,996 | €86,753 | +€10,757 | +14.2% |
| Amounts payable | 17/49 | €33,971 | €64,341 | +€30,369 | +89.4% |
| Amounts payable within one year | 42/48 | €33,971 | €64,341 | +€30,369 | +89.4% |
| Financial debts | 43 | - | €4,053 | +€4,053 | |
| Credit institutions | 430/8 | - | €4,053 | +€4,053 | |
| Trade debts | 44 | €26,158 | €35,347 | +€9,189 | +35.1% |
| Suppliers | 440/4 | €26,158 | €35,347 | +€9,189 | +35.1% |
| Taxes, remuneration and social security | 45 | €6,450 | €17,440 | +€10,990 | +170% |
| Taxes | 450/3 | €3,950 | €14,940 | +€10,990 | +278% |
| Remuneration and social security | 454/9 | €2,500 | €2,500 | = | 0.0% |
| Other amounts payable | 47/48 | €1,363 | €7,500 | +€6,137 | +450% |
| Non-recurring operating income | 76A | €4,908 | €0 | -€4,908 | -100% |
| Remuneration, social security and pensions | 62 | €28 | €0 | -€28 | -100% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,190 | €1,873 | -€317 | -14.5% |
| Other operating charges | 640/8 | €829 | €2,590 | +€1,761 | +212% |
| Non-recurring operating charges | 66A | - | €11,437 | +€11,437 | |
| Gross operating margin | 9900 | €2,949 | €33,805 | +€30,855 | +1,046% |
| Operating profit (loss) | 9901 | -€97 | €17,905 | +€18,002 | |
| Financial income | 75/76B | €6,848 | €4,629 | -€2,218 | -32.4% |
| Recurring financial income | 75 | €6,848 | €4,629 | -€2,218 | -32.4% |
| Financial charges | 65/66B | €8,960 | €6,629 | -€2,331 | -26.0% |
| Recurring financial charges | 65 | €8,960 | €6,629 | -€2,331 | -26.0% |
| Profit (loss) for the period before taxes | 9903 | -€2,210 | €15,905 | +€18,115 | |
| Income taxes | 67/77 | €677 | €5,148 | +€4,471 | +661% |
| Profit (loss) for the period | 9904 | -€2,887 | €10,757 | +€13,644 | |
| Profit (loss) for the period to be appropriated | 9905 | -€2,887 | €10,757 | +€13,644 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.